Skip to main content
Gaurang Daftary, MD, Obstetrics & Gynecology, Rochester, MN

GaurangSDaftaryMD

Obstetrics & Gynecology Rochester, MN

Reproductive Endocrinology & Infertility

Assistant Professor, Obstetrics & Gynecology, Mayo Medical School

Dr. Daftary is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Daftary's full profile

Already have an account?

  • Office

    200 1st St Sw
    Rochester, MN 55905
    Phone+1 507-284-2511

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1996 - 2000
  • Seth G.S. Medical College
    Seth G.S. Medical CollegeClass of 1992

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2008 - 2025
  • ND State Medical License
    ND State Medical License 2016 - 2017
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility

Awards, Honors, & Recognition

  • Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Publications & Presentations

PubMed

Press Mentions

  • New Clinical Data Published on Menopur (Menotropins for Injection) in a Predicted High Responder Population
    New Clinical Data Published on Menopur (Menotropins for Injection) in a Predicted High Responder PopulationMay 14th, 2020
  • Ferring Pharmaceuticals to Present New Fertility Data at ASRM 2019 Scientific Congress & Expo
    Ferring Pharmaceuticals to Present New Fertility Data at ASRM 2019 Scientific Congress & ExpoOctober 14th, 2019
  • Ferring Pharmaceuticals Adds Two Products to Its Robust Reproductive Health Portfolio in the U.S.
    Ferring Pharmaceuticals Adds Two Products to Its Robust Reproductive Health Portfolio in the U.S.January 14th, 2019
  • Join now to see all

Professional Memberships